Schedule 13D ownership disclosure

Neuronetics Inc

Common Stock, par value $0.01 per share · CUSIP: 64131A105

Event date: 2025-08-08

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • MADRYN ASSET MANAGEMENT, LPReported CIK 0001787423

    Shares: 20,737,061 · Class: 31.4%

  • MADRYN HEALTH PARTNERS II, LP

    Shares: 1,142,351 · Class: 1.7%

  • MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP

    Shares: 17,333,542 · Class: 26.2%

  • MADRYN HEALTH ADVISORS II, LP

    Shares: 18,475,893 · Class: 27.9%

  • MADRYN HEALTH ADVISORS GP II, LLC

    Shares: 18,475,893 · Class: 27.9%

  • MADRYN SELECT OPPORTUNITIES, LP

    Shares: 2,261,168 · Class: 3.4%

  • MADRYN SELECT ADVISORS, LP

    Shares: 2,261,168 · Class: 3.4%

  • MADRYN SELECT ADVISORS GP, LLC

    Shares: 2,261,168 · Class: 3.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-107330
Form type
SCHEDULE 13D/A
Filer
Madryn Asset Management, LP
CIK
CIK 1787423
Filed
Aug 12, 2025
Reporting period
Aug 08, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub